Helix Acquisition II, a blank check company formed by Cormorant Asset Management targeting healthcare, raised $160 million by offering 16 million shares at $10. The company offered 1 million more shares than anticipated. It originally planned to offer 10 million shares but revised the terms earlier this month. The SPAC plans to target the healthcare or healthcare-related industries, particularly focusing on the biotech sector.
Read the full article: Cormorant’s SPAC Helix Acquisition II Prices Further Upsized $160M IPO //
Source: https://www.renaissancecapital.com/IPO-Center/News/103247/Cormorants-SPAC-Helix-Acquisition-II-prices-further-upsized-$160-million-IP